Sanara MedTech SMTI 深 沪
已收盘 10-03 16:00:00 美东时间
31.19
+0.310
+1.00%
华盛通- 最 高31.9026
- 今 开31.75
- 成交量 6988股
- 最 低 30.81
- 昨 收 30.88
- 总市值 2.78亿
- 52周最高 39.08
- 市盈率 静 --
- 换手率 0.08%
- 52周最低 23.53
- 委 比 0.00%
- 总股本 890.24万
- 历史最高 53.85
- 量 比 0.33
- 振 幅 3.54%
- 历史最低 17.41
- 每 手 1
- 风险率 3.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sanara MedTech appoints new CEO
Sanara MedTech (NASDAQ:SMTI) has named Seth Yon as president and chief executive officer, effective September 15, 2025. Yon will also join the company’s board. Yon succeeds Ron Nixon, who will remain ...
09-03 04:50
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Sanara MedTech Inc. announced that Seth Yon has been appointed as President, CEO, and Director, effective September 15, 2025. He will succeed Ron Nixon, who remains as Executive Chairman. Yon joined the company in 2018 and has held several senior roles, contributing to significant revenue growth. Nixon praised Yon's leadership and ability to drive the company's future success. Yon expressed excitement to lead Sanara through its next phase of grow...
09-02 20:30
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
Sanara MedTech Inc. (Nasdaq: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare costs, announced that its management will present at the Cantor Global Healthcare Conference in New York on September 2-5, 2025. The fireside chat will occur on September 3 at 2:45 p.m. ET. Conference materials and a live audio webcast will be available on the Company’s investor relations website. Sanara develops and com...
08-27 20:05
HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $54
HC Wainwright & Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:SMTI) with a Buy and raises the price target from $53 to $54.
08-18 19:24
Sanara MedTech reports Q2 results
Sanara MedTech press release (NASDAQ:SMTI): Q2 GAAP EPS of -$0.23. Revenue of $25.8M (+27.7% Y/Y). Adjusted EBITDA of $2.7M, compared to $0.6M in the second quarter of 2024. More on Sanara MedTech San...
08-13 19:33
Sanara MedTech Q2 EPS $(0.23) Beats $(0.44) Estimate, Sales $25.831M Beat $25.150M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.44) by 47.73 percent. This is a 43.9 percent increase over losses of $(0.41) per share from the
08-13 19:02
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
Sanara MedTech Inc. will report its Q2 2025 financial results on August 13, 2025, before U.S. markets open. A conference call and webcast at 8:00 a.m. ET will discuss the results, with replay options available. The company, specializing in medical technologies for surgical, chronic wound, and skin markets, markets and develops products like CellerateRX® and FORTIFY TRG® to improve clinical outcomes and lower healthcare costs, and pursues strategi...
07-15 20:05
Sanara MedTech Launches Pilot Program Through Tissue Health Plus To Advance Value-Based Wound Care
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus' technology platformFORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or
07-15 04:07
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
Sanara MedTech Inc. announced the launch of a pilot program through its subsidiary, Tissue Health Plus (THP), aimed at improving chronic wound care outcomes and reducing costs. The program, a first-of-its-kind value-based offering, involves a partnership with a wound care provider group serving six states. THP's technology platform serves as the group's operating system, integrating with their electronic medical records to streamline care process...
07-14 20:05
